Empirical Antifungal Therapy in Critically Ill Patients With Sepsis: Another Case of Less Is More in the ICU

Affiliations

¹ Division of Pulmonary and Critical Care, School of Medicine, Johns Hopkins University, Baltimore, Maryland.
² Division of Infectious Diseases, School of Medicine, Johns Hopkins University, Baltimore, Maryland.

Editorial

Trishul Siddharthan et al. JAMA. 2016.

. 2016 Oct 18;316(15):1549-1550.

doi: 10.1001/jama.2016.13801.

¹ Division of Pulmonary and Critical Care, School of Medicine, Johns Hopkins University, Baltimore, Maryland.
² Division of Infectious Diseases, School of Medicine, Johns Hopkins University, Baltimore, Maryland.

No abstract available

Comment on

Empirical Micafungin Treatment and Survival Without Invasive Fungal Infection in Adults With ICU-Acquired Sepsis, Candida Colonization, and Multiple Organ Failure: The EMPIRICUS Randomized Clinical Trial.
Timsit JF, Azoulay E, Schwebel C, Charles PE, Cornet M, Souweine B, Klouche K, Jaber S, Trouillet JL, Bruneel F, Argaud L, Cousson J, Meziani F, Gruson D, Paris A, Darmon M, Garrouste-Orgeas M, Navellou JC, Foucrier A, Allaouchiche B, Das V, Gangneux JP, Ruckly S, Maubon D, Jullien V, Wolff M; EMPIRICUS Trial Group. Timsit JF, et al. JAMA. 2016 Oct 18;316(15):1555-1564. doi: 10.1001/jama.2016.14655. JAMA. 2016. PMID: 27706483 Clinical Trial.